Breaking News
November 16, 2018 - Scientist Dr David Taylor of MR Solutions is a finalist in the BMW i UK Tech Founder Awards
November 16, 2018 - Earlier treatment could help reverse autistic-like behavior in tuberous sclerosis
November 16, 2018 - Vegetables and salad may include bacteria that are resistant to antibiotics
November 16, 2018 - Endocrine Society chooses four Diabetes Caucus leaders as winners of Diabetes Champion Award
November 16, 2018 - Brain and muscle cells found within kidney organoids
November 16, 2018 - Person’s sex hormones may play key role in trauma survival, finds study
November 16, 2018 - PTEN Genetic Test: MedlinePlus Lab Test Information
November 16, 2018 - Toxic metal pollution linked with development of autism spectrum disorder
November 16, 2018 - Calcified nodules in the retina increase risk for progression to late stages of AMD
November 16, 2018 - ZEISS teams up with arivis AG to offer complete 3D imaging solutions
November 16, 2018 - Georgia State professor receives $1.2 million grant to study how the brain controls eating behavior
November 16, 2018 - Specific bacterial toxins reduce number of cells suppressing immune response
November 16, 2018 - Review by ID physician improves outcomes for outpatient parenteral antimicrobial therapy
November 16, 2018 - Conditions that produce signs similar to arthritis
November 16, 2018 - AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
November 16, 2018 - Surgery remains best treatment for appendicitis, Stanford study finds
November 16, 2018 - Non-surgical fistula creation system Ellipsys becomes key focus of attention at CiDA
November 16, 2018 - Researchers find no link between ‘allergy friendly’ dogs and lower risk of asthma
November 16, 2018 - Researchers elucidate new rules of connectivity of neurons in the neocortex
November 16, 2018 - Treating children with ‘bubble baby disease’
November 16, 2018 - Nexus announces availability of Arsenic Trioxide Injection in the US
November 16, 2018 - Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis
November 16, 2018 - AHA: PTSD Common Among Those Who Suffer Tear in the Aorta’s Wall
November 16, 2018 - Many RA patients’ pain related to central nervous system
November 16, 2018 - Changes in Himalayan gut microbiomes linked to diet
November 16, 2018 - Inhibition of prostaglandin E2 enhances ability to combat infectious colitis
November 16, 2018 - Chronic dry eye can slow reading rate and disrupt day to day tasks
November 16, 2018 - Researchers develop new drug molecule that inhibits inflammation
November 16, 2018 - Dementia symptoms peak in winter and spring, study finds
November 16, 2018 - Stanford tobacco researcher weighs in on JUUL
November 16, 2018 - Increasing omega-3 fatty acid intake during pregnancy reduces risk of premature birth, review finds
November 16, 2018 - Researchers find no link between infants waking up at night and later developmental problems
November 16, 2018 - Both parents and children agree about confidential medical services
November 16, 2018 - FDA warns against use of unapproved pain medications with implanted pumps
November 16, 2018 - Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer’s disease
November 16, 2018 - Study provides new insight into norovirus outbreaks, may help guide efforts to develop vaccines
November 16, 2018 - Inexpensive, portable air purifier could help protect the heart from pollution
November 16, 2018 - New 15-minute scan could help diagnose brain damage in babies up to two years old
November 16, 2018 - Deep brain stimulation not effective for treating early Alzheimer’s
November 16, 2018 - Traditional chemotherapy superior to new alternative for oropharyngeal cancers | News Center
November 16, 2018 - What This Pond Protist Does With Its Genome Will Astound You
November 15, 2018 - Researchers develop tool that speeds up analysis and publication of biomedical data
November 15, 2018 - Scientists identify mechanism used by lung cancer cells to obtain glucose
November 15, 2018 - Abnormalities in development of the brain could be involved in onset of autism, finds new study
November 15, 2018 - Soy protein equally effective as animal protein in building muscle strength
November 15, 2018 - American Academy of Pediatrics, Nov. 2-6
November 15, 2018 - Dopamine drives early addiction to heroin
November 15, 2018 - Variance in gut microbiome in Himalayan populations linked to dietary lifestyle | News Center
November 15, 2018 - Reducing Cardiovascular Disease: The Amish Way
November 15, 2018 - King’s researchers launch charter to guide organizations to engage abuse survivors in research
November 15, 2018 - Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals
November 15, 2018 - TGen North collaborates with NARBHA Institute to advance human health
November 15, 2018 - Researchers discover molecular basis for therapeutic actions of an African folk medicine
November 15, 2018 - Human Cell Atlas study of early pregnancy shows how mother’s immune system is modified
November 15, 2018 - New guidelines for detecting and managing sarcopenia to be launched in the UK
November 15, 2018 - Researchers explore role of dietary composition on energy expenditure
November 15, 2018 - Elsevier launches Entellect™ Platform, unlocking value by creating AI-ready life sciences data
November 15, 2018 - Now that cannabis is legal in Canada, let’s use it to tackle the opioid crisis
November 15, 2018 - In the Spotlight: At the intersection of tech, health, and ethics
November 15, 2018 - Traditional Glaucoma Test Can Miss Severity of the Disease
November 15, 2018 - Researchers directly connect activities of genes with instinctive behavior in male cichlids
November 15, 2018 - Salk researchers report new methods to identify AD drug candidates with anti-aging properties
November 15, 2018 - St. Jude Hospital announces availability of largest collections of leukemia samples
November 15, 2018 - Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline
November 15, 2018 - Designing a novel cell-permeable peptide chimera to promote wound healing
November 15, 2018 - NEI investigators combine two imaging modalities to view the retina in unprecedented detail
November 15, 2018 - Determining how hearts develop to better understand congenital heart defects
November 15, 2018 - Maverick immune cells can act independently to identify and kill cancer cells, finds research
November 15, 2018 - Advanced AI and big data methods to tackle dementia
November 15, 2018 - Report reveals increase in pancreatic cancer death rates across Europe
November 15, 2018 - Luxia Scientific announces availability of its gut microbiome test in Luxembourg
November 15, 2018 - New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis
November 15, 2018 - New approach targets matrix surrounding neurons to protect neurons after stroke
November 15, 2018 - Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine
November 15, 2018 - Heart failure patients shouldn’t stop meds even if condition improves: study
November 15, 2018 - Parents and carers of people with diabetes experience emotional or mental health problems
November 15, 2018 - RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders
November 15, 2018 - Breakthrough research could lead to a new wave of cancer-fighting antibodies
November 15, 2018 - Mylan and Biocon launch new insulin glargine biosimilar in the UK
November 15, 2018 - For wildfire safety, only particular masks guard against toxic particulate matter
Could we prevent Alzheimer’s disease by treating herpes?

Could we prevent Alzheimer’s disease by treating herpes?

image_pdfDownload PDFimage_print

An exciting new review paper by Professor Ruth Frances Itzhaki suggests that over half of all cases of Alzheimer’s disease could be traced back to Herpes Simplex Virus 1 (HSV1) ; the virus responsible for cold sores and genital herpes.

HerpesvirusImage Credit: Lightspring / Shutterstock

Importantly, the research suggests that the use of antivirals to treat severe herpes virus infection could reduce the risk of senile dementia.

The review, which traces Dr. Itzhaki’s lifetime of work on the causation of Alzheimer’s disease, was recently published in the journal, Frontiers in Ageing Neuroscience.

If confirmed, this groundbreaking work points to an inexpensive and effective means of preventing Alzheimer’s disease, which is one of the most costly medical conditions in the world.

HSV1 underlies Alzheimer’s disease

Herpes simplex virus 1 (HSV1) is notorious for its tendency to remain dormant in a patient’s neurons and immune system.

The infection is reactivated under conditions of weakened immunity or stress. This results in the reappearance of cold sores. Most older adults show the presence of antibodies against HSV1.

In older studies, Itzhaki had shown that cold sores are more common in patients who carry the gene variant APOE-ε4, which is also associated with a higher risk of Alzheimer’s disease.

She theorizes that Apolipoprotein E-ε4 (ApoE-ε4), which has been strongly linked to Alzheimer’s disease, predisposes the patient to more frequent or damaging reactivations of HSV1 in the neurons of the brain. This causes harmful changes within the neurons to accumulate, resulting in Alzheimer’s disease.

Proving the link

In most countries there simply isn’t enough population data to put the HSV1 theory to the test, since information on the reduction of dementia risk in individuals treated with antivirals, for instance, is not typically collected.

Taiwanese scientists have succeeded in accumulating this type of data, however.

The National Health Insurance Research Database has over 99.9% of the population on its rolls, and data mining of this vast repository is underway in multiple areas to explore contagious diseases and other conditions.

As a result, 2017-18 witnessed the publication of three separate reports on the Taiwanese data relating to the occurrence of senile dementia, caused mainly by Alzheimer’s disease, as well as on the treatment of patients who have frank HSV or VZV (varicella-zoster virus, chickenpox virus) infection.

The striking results include evidence that the risk of senile dementia is much greater in those who are infected with HSV, and that anti-herpes antiviral treatment causes a dramatic decrease in the number of those subjects severely affected by HSV1 who later develop dementia.”

How does this work? Itzhaki and her colleagues already demonstrated that HSV1 infection led to the characteristic neuronal plaques and neurofibrillary tangles of Alzheimer’s disease, which supports the epidemiological findings.

This was proven by the presence of viral DNA within amyloid plaques in brains of patients with Alzheimer’s disease at postmortem.

In addition, in cell cultures infected with HSV1, both amyloid plaques and tau tangles accumulate, but this can be inhibited by the use of antivirals.

Preventing Alzheimer’s disease

Dr. Itzhaki stresses that the Taiwanese data apply only to severe infections with HSV1 or VZV, which are atypical.

To strengthen their findings, detailed epidemiological data on dementia would need to be drawn from people with mild HSV1 infection (both cold sores and genital herpes). This data is difficult to find, however, with barely any records.

The focus of future research will be to verify the observation that HSV1 infection is causally related to Alzheimer’s disease and to define the nature of this link.

However, Itzhaki is already looking forward to the exciting prospect of being able to treat this widespread and often disabling condition with antiviral drugs directed against HSV1.

Taking inspiration from the global use of human papillomavirus (HPV) immunization to protect against cervical cancer, the research team is hopeful that uncovering this virus-disease link will lead to the effective treatment and prevention of Alzheimer’s disease, by a vaccine against HSV1, for instance.

Considering that over 150 publications strongly support an HSV1 role in Alzheimer’s, these Taiwan fndings greatly justify usage of antiherpes antivirals – which are safe and well-tolerated – to treat Alzheimer’s disease. They also incentivize development of an HSV1 vaccine, which would likely be the most effective treatment.”

Source:

This news story is based on a press release by the journal, Frontiers in Ageing Neuroscience, and the review itself, entitled “Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease” which was published today.

Tagged with:

About author

Related Articles